Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
African Trypanosomiasis - Overview
African Trypanosomiasis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
African Trypanosomiasis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
African Trypanosomiasis - Companies Involved in Therapeutics Development
F. Hoffmann-La Roche Ltd
Novartis AG
Pfizer Inc
Sanofi
Scynexis Inc
African Trypanosomiasis - Drug Profiles
acoziborole - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AP-3 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CBL-0137 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DDD-100097 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
fexinidazole - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GNF-6702 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MDL-73811 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
melarsoprol hydroxypropylbetadex - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MS-08 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Peptides for Sleeping Sickness - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SCYX-1330682 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SCYX-1608210 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Infectious Diseases - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Protozoal Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Sleeping Sickness - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Lanosterol 14 alpha-Demethylase for African Trypanosomiasis, Chagas Disease and Leishmaniasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit N-Myristoyltransferase for African Trypanosomiasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Rhodesain for African Trypanosomiasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Variant Surface Glycoprotein for African Trypanosomiasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
African Trypanosomiasis - Dormant Projects
African Trypanosomiasis - Discontinued Products
African Trypanosomiasis - Product Development Milestones
Featured News & Press Releases
Nov 16, 2018: Sanofi: European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness
Nov 16, 2018: CHMP recommends first oral-only treatment for sleeping sickness
Jan 31, 2018: Sanofi, DNDi seek European Medicines Agency review for sleeping sickness treatment
Nov 04, 2017: Phase II/III Studies Show High Efficacy and Safety of Fexinidazole, the First Oral Treatment for Sleeping Sickness
Aug 30, 2016: UGA researchers discover a drug for a tropical disease
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for African Trypanosomiasis, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Number of Products by Targets, H2 2019
Number of Products by Stage and Targets, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019

 

List of Tables


Number of Products under Development for African Trypanosomiasis, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
African Trypanosomiasis - Pipeline by F. Hoffmann-La Roche Ltd, H2 2019
African Trypanosomiasis - Pipeline by Novartis AG, H2 2019
African Trypanosomiasis - Pipeline by Pfizer Inc, H2 2019
African Trypanosomiasis - Pipeline by Sanofi, H2 2019
African Trypanosomiasis - Pipeline by Scynexis Inc, H2 2019
African Trypanosomiasis - Dormant Projects, H2 2019
African Trypanosomiasis - Discontinued Products, H2 2019